Table 2. Distribution, RIs of tumor marker levels, and 90% confidence intervals.
Tumor markers | Gastric cancer (n = 268) | Control (n = 209) | ||
---|---|---|---|---|
M (IQR) | M (IOR) | Reference intervals | 90% CI | |
AFP (ng/ml) | 1.36 (2.05) | 1.26 (0.94) | 0–3.69 | [3.02–5.49] |
NSE (ng/ml) | 2.59 (1.09) | 2.55 (1.21) | 0–4.33 | [4.17–4.96] |
FER (ng/ml) | 76.91 (160.11) | 138.03 (202.03) | 0–376.87 | [365.96–424.65] |
CEA (ng/ml) | 1.47 (2.39) | 1.07 (0.94) | 0–3.18 | [2.77–3.82] |
CA125 (U/ml) | 7.31 (10.14) | 8.55 (5.65) | 0–20.46 | [16.82–32.90] |
CA153 (U/ml) | 4.54 (3.75) | 7.01 (7.62) | 0–24.46 | [21.27–27.91] |
CA199 (U/ml) | 10.35 (18.61) | 7.47 (7.36) | 0–24.23 | [19.45–29.37] |
CA242 (U/ml) | 3.28 (4.79) | 3.04 (2.01) | 0–7.61 | [6.70–8.95] |